Exact Mass: 534.2947872
Exact Mass Matches: 534.2947872
Found 500 metabolites which its exact mass value is equals to given mass value 534.2947872
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neriifolin
Neriifolin is a cardenolide glycoside that is digitoxigenin in which the hydroxy goup at position 3 has been converted to its (6-deoxy-3-O-methyl-alpha-L-glucopyranoside derivative. Found in the seeds of Cerbera odollamand in Thevetia ahouia and Thevitia neriifolia. It has a role as a cardiotonic drug, a toxin and a neuroprotective agent. It is functionally related to a digitoxigenin. Neriifolin is a natural product found in Cerbera manghas, Cerbera odollam, and other organisms with data available. A cardenolide glycoside that is digitoxigenin in which the hydroxy goup at position 3 has been converted to its (6-deoxy-3-O-methyl-alpha-L-glucopyranoside derivative. Found in the seeds of Cerbera odollamand in Thevetia ahouia and Thevitia neriifolia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides [Raw Data] CB071_Neriifolin_pos_40eV_CB000031.txt [Raw Data] CB071_Neriifolin_pos_10eV_CB000031.txt [Raw Data] CB071_Neriifolin_pos_20eV_CB000031.txt [Raw Data] CB071_Neriifolin_pos_50eV_CB000031.txt [Raw Data] CB071_Neriifolin_pos_30eV_CB000031.txt Neriifolin, a CNS-penetrating cardiac glycoside, is an inhibitor of the Na+, K+-ATPase. Neriifolin can target beclin 1, inhibits the formation of LC3-associated phagosomes and ameliorates experimental autoimmune encephalomyelitis (EAE) development. Neriifolin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells[1][2. Neriifolin, a CNS-penetrating cardiac glycoside, is an inhibitor of the Na+, K+-ATPase. Neriifolin can target beclin 1, inhibits the formation of LC3-associated phagosomes and ameliorates experimental autoimmune encephalomyelitis (EAE) development. Neriifolin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells[1][2.
Divaside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Corchoroside A
Constituent of Corchorus olitorius (Jews mallow) and Hesperis matronalis (sweet rocket). Corchoroside A is found in tea, herbs and spices, and green vegetables. Helveticoside is found in herbs and spices. Helveticoside is a constituent of Hesperis matronalis (sweet rocket) D020011 - Protective Agents > D002316 - Cardiotonic Agents > D004071 - Digitalis Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins
GV 150013X
Corotoxigenin-3-o-alpha-L-rhamnopyranoside
Pyropheophorbide a
Pyropheophorbide-a (Ppa) is a promising photosensitizer for tumor photodynamic therapy (PDT)[1].
Ganoderic acid L
Ganoderic acid L is found in mushrooms. Ganoderic acid L is a metabolite of Ganoderma lucidum (reishi
3-Hydroxy-beta-ionol 3-[glucosyl-(1->6)-glucoside]
3-Hydroxy-beta-ionol 3-[glucosyl-(1->6)-glucoside] is found in fruits. 3-Hydroxy-beta-ionol 3-[glucosyl-(1->6)-glucoside] is a constituent of Cydonia oblonga (quince). Constituent of Cydonia oblonga (quince). 3-Hydroxy-beta-ionol 3-[glucosyl-(1->6)-glucoside] is found in fruits.
7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside]
7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside] is found in fruits. 7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside] is a constituent of leaves of quince (Cydonia vulgaris)
Pyrophaeophorbide a
Pyrophaeophorbide a is found in tea. Pyrophaeophorbide a is isolated from te Pyropheophorbide-a (Ppa) is a promising photosensitizer for tumor photodynamic therapy (PDT)[1].
8-{2-Methyl-5-[2-oxo-2-(4-phenyl-piperazin-1-yl)-ethoxy]-2H-pyrazol-3-yl}-1,3-dipropyl-3,7-dihydro-purine-2,6-dione
Daglutril
C31H38N2O6 (534.2729727999999)
Phytoporphyrin
Pyropheophorbide a
PA(2:0/20:3(8Z,11Z,14Z)-2OH(5,6))
C25H43O10P (534.2593707999999)
PA(2:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0)
C25H43O10P (534.2593707999999)
PA(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(8Z,11Z,14Z)-2OH(5,6)/2:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Periplocymarin
4-[(3S,5S,10R,13R,14S,17S)-5,14-Dihydroxy-3-[(2S,5R)-5-hydroxy-4-methoxy-6-methyl-oxan-2-YL]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[A]phenanthren-17-YL]-5H-furan-2-one is a natural product found in Periploca sepium, Periploca forrestii, and other organisms with data available. Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2]. Periplocymarin, a cardiac glycoside isolated from Periploca sepium and Periploca graeca, is a potential anti-cancer compound[1][2].
OCHROCARPINONE A
A beta-diketone isolated from Ochrocarpos punctatus and has been shown to exhibit antineoplastic activity.
Kalimantacin C
A fatty acid derivative isolated from the fermentation broth of Alcaligenes sp. YL-02632S. It is an antibiotic with antibacterial activity.
3-[(3,4-dihydroxyphenyl)(hydroxy)methylene]-6,6-dimethyl-1,5,7-tris(3-methyl-2-buten-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione
Vitixanthin
2,16,19,20,25-Pentahydroxycucurbit-5-ene-3,11,22-trione
9-hydroxy-9-[[(E)-2-(hydroxymethyl)-3-[3-(hydroxymethyl)-6-propan-2-ylcyclohex-2-en-1-yl]prop-2-enoyl]oxymethyl]-1-oxo-6-propan-2-yl-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
3beta-beta-D-Glucopyranosyloxy-15xi-hydroxy-5beta,14xi-carda-16,20(22)-dienolid|3beta-beta-D-glucopyranosyloxy-15xi-hydroxy-5beta,14xi-carda-16,20(22)-dienolide
(1R*,3S*,5S*,6aR*,7R*,8R*,9S*,10S*,10aR*)-1,10-bis(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-9-hydroxy-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]naphtho[1,8a-c]furan-3-yl butanoate
6alpha,7alpha-epoxy-5beta-hydroxy-12-deoxyphorbol-13-decanoate
2beta,9-dihydroxymegastigma-4-en-3-one 9-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
14,16beta-dihydroxy-3beta-(O3-methyl-alpha-L-arabino-2,6-dideoxy-hexopyranosyloxy)-5beta,14beta-card-20(22)-enolide|14,16beta-Dihydroxy-3beta-(O3-methyl-alpha-L-arabino-2,6-didesoxy-hexopyranosyloxy)-5beta,14beta-card-20(22)-enolid|deacetyloleandrin|Desacetyl-oleandrin
3beta-O-(beta-D-diginosyl)-8,14-dihydroxy-5beta,14beta-card-20(22)-enolide
2alpha,3alpha,19alpha,25-tetrahydroxyurs-12-en-23,28-dioic acid
(13-hydroxyblumenol C) 9-O-beta-(6-O-rhamnosylglucoside)
Ajugamarin F4
3-O-beta-D-(6-O-linolenoyl)glucopyranosyl-gamma-pyranone
3,4,7-O-trimethylnymphaeol C|3,4,7-O-trimethylpropolin G
digitoxigenin-6-deoxy-2-O-methyl-beta-D-allopyranoside|epi-reevesioside F
6alpha,18-diacetoxy-4alphahydroxy-19-tigloyloxy-neo-clerod-13-en-15,16-olide
(8E,12E,14E)-7-acetoxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-21-oxo-18,19-epoxytricosa-8,12,14-trien-11-olide
Delta(16)-digitoxigenin beta-D-glucoside|Delta16-digitoxigenin beta-D-glucoside
3beta-O-(beta-D-diginosyl)-14,15alpha-dihydroxy-5alpha-card-20(22)-enolide
2beta,3beta,16alpha,20(R),25-pentahydroxy-9-methyl-19-norlanost-5-en-7,11,22-trione
(1alpha,3beta,20RS,22RS,24RS,25RS)-3,20,22,25-tetrahydroxy-26-oxo-26,28-epoxyergost-5-en-1-yl acetate|perulactone C
(3beta,5alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxy-11-oxocard-20(22)-enolide|11-oxouzarigenin 3-(alpha-L-rhamnopyranoside)
12alpha-Brom-3beta,13-dihydroxy-oleanan-28-saeure-13-lacton|12alpha-bromo-3beta,13-dihydroxy-oleanan-28-oic acid-13-lactone|12alpha-bromo-3beta,13beta-dihydroxyolean-28-oic acid gamma-lactone|12alpha-bromo-3beta-hydroxy-oleanan-13beta,28-olide
3??,7??,20,23?鈥?Tetrahydroxy-11,15-dioxolanosta-8-en-26-oic acid
2??-Acetoxy-4??-hydroxy-6??-p-hydroxybenzoyloxy-10??-benzoyloxy-dauc-8-ene
Phe Ile Gln Lys
Gln Phe Ile Lys
[1,3-diacetyloxy-9,10-dihydroxy-7,8-dimethyl-7-(3-methylidenepent-4-enyl)-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-5-yl] 2-methylbutanoate
C29H42O9_9-Hydroxy-9-[({(2E)-2-(hydroxymethyl)-3-[3-(hydroxymethyl)-6-isopropyl-2-cyclohexen-1-yl]-2-propenoyl}oxy)methyl]-6-isopropyl-1-oxo-1,3,5a,6,7,8,9,9a-octahydro-2-benzoxepine-4-carboxylic acid
C29H42O9_Carda-5,20(22)-dienolide, 3-(beta-D-glucopyranosyloxy)-14-hydroxy-, (3beta,9xi)
C30H46O8_(1alpha,2alpha,3beta,5xi,9xi,13xi,14xi,18xi)-1,2,3,22,23,29-Hexahydroxy-13,27-cycloolean-11-en-28-oic acid
C30H46O8_Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-, (3beta,5beta,8xi,9xi,17alpha)
3-[(3S,5R,10S,13R,14S,17S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
SB236057A
CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8057; ORIGINAL_PRECURSOR_SCAN_NO 8055 CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8094; ORIGINAL_PRECURSOR_SCAN_NO 8093 CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8100; ORIGINAL_PRECURSOR_SCAN_NO 8098 CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8129; ORIGINAL_PRECURSOR_SCAN_NO 8126 CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8145; ORIGINAL_PRECURSOR_SCAN_NO 8143 CONFIDENCE standard compound; INTERNAL_ID 629; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8145; ORIGINAL_PRECURSOR_SCAN_NO 8144
9-hydroxy-9-[[(E)-2-(hydroxymethyl)-3-[3-(hydroxymethyl)-6-propan-2-ylcyclohex-2-en-1-yl]prop-2-enoyl]oxymethyl]-1-oxo-6-propan-2-yl-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid_major
9-hydroxy-9-[[(E)-2-(hydroxymethyl)-3-[3-(hydroxymethyl)-6-propan-2-ylcyclohex-2-en-1-yl]prop-2-enoyl]oxymethyl]-1-oxo-6-propan-2-yl-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid_21.8\\%
Ala Lys Met Trp
Ala Lys Trp Met
Ala Met Lys Trp
Ala Met Trp Lys
Ala Trp Lys Met
Ala Trp Met Lys
Cys Glu Lys Arg
Cys Glu Arg Lys
Cys Lys Glu Arg
Cys Lys Arg Glu
Cys Lys Val Trp
Cys Lys Trp Val
Cys Arg Glu Lys
Cys Arg Lys Glu
Cys Arg Arg Thr
Cys Arg Thr Arg
Cys Thr Arg Arg
Cys Val Lys Trp
Cys Val Trp Lys
Cys Trp Lys Val
Cys Trp Val Lys
Glu Cys Lys Arg
Glu Cys Arg Lys
Glu Lys Cys Arg
Glu Lys Lys Met
Glu Lys Met Lys
Glu Lys Arg Cys
Glu Met Lys Lys
Glu Arg Cys Lys
Glu Arg Lys Cys
Phe Gly Arg Arg
C23H38N10O5 (534.3026497999999)
Phe Ile Lys Gln
Phe Ile Gln Gln
Phe Lys Ile Gln
Phe Lys Leu Gln
Phe Lys Gln Ile
Phe Lys Gln Leu
Phe Leu Lys Gln
Phe Leu Gln Lys
Phe Leu Gln Gln
Phe Asn Arg Val
Phe Asn Val Arg
Phe Gln Ile Lys
Phe Gln Ile Gln
Phe Gln Lys Ile
Phe Gln Lys Leu
Phe Gln Leu Lys
Phe Gln Leu Gln
Phe Gln Gln Ile
Phe Gln Gln Leu
Phe Arg Gly Arg
C23H38N10O5 (534.3026497999999)
Phe Arg Asn Val
Phe Arg Arg Gly
C23H38N10O5 (534.3026497999999)
Phe Arg Val Asn
Phe Val Asn Arg
Phe Val Arg Asn
Gly Phe Arg Arg
C23H38N10O5 (534.3026497999999)
Gly Arg Phe Arg
C23H38N10O5 (534.3026497999999)
Gly Arg Arg Phe
C23H38N10O5 (534.3026497999999)
His His Lys Asn
His His Asn Lys
His Lys His Asn
His Lys Asn His
His Asn His Lys
His Asn Lys His
Ile Phe Lys Gln
Ile Phe Gln Lys
Ile Phe Gln Gln
Ile Lys Phe Gln
Ile Lys Gln Phe
Ile Gln Phe Lys
Ile Gln Phe Gln
Ile Gln Lys Phe
Ile Gln Gln Phe
Lys Ala Met Trp
Lys Ala Trp Met
Lys Cys Glu Arg
Lys Cys Arg Glu
Lys Cys Val Trp
Lys Cys Trp Val
Lys Glu Lys Met
Lys Glu Met Lys
Lys Phe Ile Gln
Lys Phe Leu Gln
Lys Phe Gln Ile
Lys Phe Gln Leu
Lys His His Asn
Lys His Asn His
Lys Ile Phe Gln
Lys Ile Gln Phe
Lys Lys Glu Met
Lys Lys Met Glu
Lys Lys Pro Tyr
Lys Lys Tyr Pro
Lys Leu Phe Gln
Lys Leu Gln Phe
Lys Met Ala Trp
Lys Met Glu Lys
Lys Met Lys Glu
Lys Met Arg Thr
Lys Met Thr Arg
Lys Met Trp Ala
Lys Asn His His
Lys Pro Lys Tyr
Lys Pro Gln Tyr
Lys Pro Tyr Lys
Lys Pro Tyr Gln
Lys Gln Phe Ile
Lys Gln Phe Leu
Lys Gln Ile Phe
Lys Gln Leu Phe
Lys Gln Pro Tyr
Lys Gln Tyr Pro
Lys Arg Met Thr
Lys Arg Thr Met
Lys Thr Met Arg
Lys Thr Arg Met
Lys Thr Thr Trp
Lys Thr Trp Thr
Lys Val Cys Trp
Lys Val Trp Cys
Lys Trp Ala Met
Lys Trp Cys Val
Lys Trp Met Ala
Lys Trp Thr Thr
Lys Trp Val Cys
Lys Tyr Lys Pro
Lys Tyr Pro Lys
Lys Tyr Pro Gln
Lys Tyr Gln Pro
Leu Phe Lys Gln
Leu Phe Gln Lys
Leu Phe Gln Gln
Leu Lys Phe Gln
Leu Lys Gln Phe
Leu Gln Phe Lys
Leu Gln Phe Gln
Leu Gln Lys Phe
Leu Gln Gln Phe
Met Ala Lys Trp
Met Ala Trp Lys
Met Glu Lys Lys
Met Lys Ala Trp
Met Lys Glu Lys
Met Lys Lys Glu
Met Lys Arg Thr
Met Lys Thr Arg
Met Lys Trp Ala
Met Arg Lys Thr
Met Arg Thr Lys
Met Thr Lys Arg
Met Thr Arg Lys
Met Trp Ala Lys
Met Trp Lys Ala
Asn Phe Arg Val
Asn Phe Val Arg
Asn His His Lys
Asn His Lys His
Asn Lys His His
Asn Arg Phe Val
Asn Arg Val Phe
Asn Val Phe Arg
Asn Val Arg Phe
Pro Lys Lys Tyr
Pro Lys Gln Tyr
Pro Lys Tyr Lys
Pro Lys Tyr Gln
Pro Gln Lys Tyr
Pro Gln Tyr Lys
Pro Tyr Lys Lys
Pro Tyr Lys Gln
Pro Tyr Gln Lys
Gln Phe Ile Gln
Gln Phe Lys Ile
Gln Phe Lys Leu
Gln Phe Leu Lys
Gln Phe Leu Gln
Gln Phe Gln Ile
Gln Phe Gln Leu
Gln Ile Phe Lys
Gln Ile Phe Gln
Gln Ile Lys Phe
Gln Ile Gln Phe
Gln Lys Phe Ile
Gln Lys Phe Leu
Gln Lys Ile Phe
Gln Lys Leu Phe
Gln Lys Pro Tyr
Gln Lys Tyr Pro
Gln Leu Phe Lys
Gln Leu Phe Gln
Gln Leu Lys Phe
Gln Leu Gln Phe
Gln Pro Lys Tyr
Gln Pro Tyr Lys
Gln Gln Phe Ile
Gln Gln Phe Leu
Gln Gln Ile Phe
Gln Gln Leu Phe
Gln Tyr Lys Pro
Gln Tyr Pro Lys
Arg Cys Arg Thr
Arg Cys Thr Arg
Arg Phe Gly Arg
C23H38N10O5 (534.3026497999999)
Arg Phe Asn Val
Arg Phe Arg Gly
C23H38N10O5 (534.3026497999999)
Arg Phe Val Asn
Arg Gly Phe Arg
C23H38N10O5 (534.3026497999999)
Arg Gly Arg Phe
C23H38N10O5 (534.3026497999999)
Arg Lys Met Thr
Arg Lys Thr Met
Arg Met Lys Thr
Arg Met Thr Lys
Arg Asn Phe Val
Arg Asn Val Phe
Arg Arg Cys Thr
Arg Arg Phe Gly
C23H38N10O5 (534.3026497999999)
Arg Arg Gly Phe
C23H38N10O5 (534.3026497999999)
Arg Arg Thr Cys
Arg Thr Cys Arg
Arg Thr Lys Met
Arg Thr Met Lys
Arg Thr Arg Cys
Arg Val Phe Asn
Arg Val Asn Phe
Thr Cys Arg Arg
Thr Lys Met Arg
Thr Lys Arg Met
Thr Lys Thr Trp
Thr Lys Trp Thr
Thr Met Lys Arg
Thr Met Arg Lys
Thr Arg Cys Arg
Thr Arg Lys Met
Thr Arg Met Lys
Thr Arg Arg Cys
Thr Thr Lys Trp
Thr Thr Trp Lys
Thr Trp Lys Thr
Thr Trp Thr Lys
Val Cys Lys Trp
Val Cys Trp Lys
Val Phe Asn Arg
Val Phe Arg Asn
Val Lys Cys Trp
Val Lys Trp Cys
Val Asn Phe Arg
Val Asn Arg Phe
Val Arg Phe Asn
Val Arg Asn Phe
Val Trp Cys Lys
Val Trp Lys Cys
Trp Ala Lys Met
Trp Ala Met Lys
Trp Cys Lys Val
Trp Cys Val Lys
Trp Lys Ala Met
Trp Lys Cys Val
Trp Lys Met Ala
Trp Lys Thr Thr
Trp Lys Val Cys
Trp Met Ala Lys
Trp Met Lys Ala
Trp Thr Lys Thr
Trp Thr Thr Lys
Trp Val Cys Lys
Trp Val Lys Cys
Tyr Lys Lys Pro
Tyr Lys Pro Lys
Tyr Lys Pro Gln
Tyr Lys Gln Pro
Tyr Pro Lys Lys
Tyr Pro Lys Gln
Tyr Pro Gln Lys
Tyr Gln Lys Pro
Tyr Gln Pro Lys
7,8-Dihydrovomifoliol 9-[rhamnosyl-(1->6)-glucoside]
Erizimin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Ganoderic acid L
3-Higgp
dasc#1
9-[2-(Butoxycarbonyl)phenyl]-6-(diethylamino)-N,N-diethyl-3H-xant hen-3-iminium chloride
1-Piperazinecarboxylic acid, 4-[6-[[7-cyclopentyl-6-[(diMethylaMino)carbonyl]-7H-pyrrolo[2,3-d]pyriMidin-2-yl]aMino]-3-pyridinyl]-, 1,1-diMethylethyl ester
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid,styrene
L-Leucinamide,N,N-dimethyl-L-phenylalanyl-(3S)-3-hydroxy-L-leucyl-N-[(1Z)-2-(4-hydroxyphenyl)ethenyl]-,cyclic (2®3)-ether
Daglutril
C31H38N2O6 (534.2729727999999)
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Acetamide, N-[3-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)propyl]-N-[4-[[3-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)propyl]amino]butyl]-
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents Otaplimastat (SP-8203), a matrix metalloproteinase (MMP) inhibitor, blocks N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity in a competitive manner. Otaplimastat also exhibits anti-oxidant activity. Otaplimastat can be used for the research of brain ischemic injury[1][2][3].
1H-1-Benzazepine-1-acetic acid, 3-[[[1-[2-(ethoxycarbonyl)-4-phenylbutyl]cyclopentyl]carbonyl]amino]-2,3,4,5-tetrahydro-2-oxo-
C31H38N2O6 (534.2729727999999)
1-[(3R)-1-(1-adamantylmethyl)-2,4-dioxo-5-phenyl-1,5-benzodiazepin-3-yl]-3-phenylurea
fatsicarpain B
A pentacyclic triterpenoid that is oleana-11,13(18)-diene substituted by a sulfoxy group at position 3 and a carboxy group at position 28. It has been isolated from the leaves and twigs of Fatsia polycarpa.
(1-Ethyl-6,7-dihydro-5H-spiro(furo(2,3-f)indole-3,4-piperidin)-5-yl)(2-methyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-yl)methanone
N-Methylalanyl-3-methylvalyl-4-phenoxy-N-(1,2,3,4-tetrahydronaphthalen-1-YL)prolinamide
alleoside a
A cardenolide glycoside that consists of strophanthidin having a digitoxosyl group attached at position 3. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D004071 - Digitalis Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins
3-[(21S,22S)-16-ethenyl-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
longirostrerone D
A natural product found in Chaetomium longirostre. An azaphilone that is 6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 4-hydroxy-2-methyl-6-oxocyclohexyl group at position 3, a methyl group at position 6a, and a 4,6,8-trimethyldeca-2,4-dienoyl group at position 9. Isolated from Chaetomium longirostre, it exhibits cytotoxic activities.
Eurysterol B
An organic sodium salt that is monosodium salt of eurysterol B sulfonic acid. Isolated from an undescribed marine sponge of the genus Euryspongia collected in Palau, it is cytotoxic and exhibits antifungal activity against both amphotericin B-resistant and wild-type strains of Candida albicans.
sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,5R)-2,5-dimethoxy-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
A natural product found in Coscinoderma species.
rel-6alpha,7alpha-Epoxy-5beta-hydroxy-12-deoxyphorbol-13-decanoate
A natural product found in Pimelea elongata.
(2R,7R,8R,9R,10S,20S)-7,8,9,19-tetrahydroxy-6,17-bis(hydroxymethyl)-2,6,10,17-tetramethylhexacyclo[12.8.1.01,14.02,11.05,10.015,20]tricos-12-ene-20-carboxylic acid
caseamemebrol B
A diterpenoid of the clerodane group isolated from the leaves and twigs of Casearia membranacea. It exhibits significant cytotoxicity against human prostrate (PC-3) cancer cells.
1-(4-fluorophenyl)-3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(phenylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
(20ξ)-3β,7β,15α,20-Tetrahydroxy-11,23-dioxo-5α-lanost-8-en-26-oic acid
3-(dimethylamino)-N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
1-[[(2R,3S)-8-(2-benzofuranyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-cyclohexyl-1-methylurea
3-(dimethylamino)-N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
3-(dimethylamino)-N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpropanamide
3-[(3S,5R,8R,9S,10S,11R,13R,14S,17R)-11,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]cyclopent-2-en-1-one
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1,3-Diacetyloxy-9,10-dihydroxy-7,8-dimethyl-7-(3-methylidenepent-4-enyl)-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-5-yl] 2-methylbutanoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C25H43O10P (534.2593707999999)
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C25H43O10P (534.2593707999999)
2-[[3-acetyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
Divaricoside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Pyrophaeophorbide a
Pyropheophorbide-a (Ppa) is a promising photosensitizer for tumor photodynamic therapy (PDT)[1].
Corchoroside A
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides